Yangtze River Pharmaceutical Group

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie To Pay $48m Up Front For Preclin

Top pharma and biotech executives fared relatively poorly in 2022 and among all sectors represented in the just-released ranking of the world's wealthiest people, biotech was among the worst performin

Yangtze River Pharma has become the first pharma firm to receive a hefty fine amid a new wave of antitrust crackdowns in China that started with big tech companies but is now quickly expanding to othe

AbbVie Inc. is the latest biotech giant to claim that a competitor obtained trade secrets stolen by a former employee to help it advance development of a biosimilar. The case is somewhat different as